News

NFL funds Canadian research into cannabis QuickStrip product

Published on May 31, 2024 by Pat Bulmer

Photo: Adobe stock/the oz.

A Canadian biotech company and university researchers are working with the National Football League to determine if ingredients in cannabis plants can help treat concussions.

Burlington, Ont.-based Rapid Dose Therapeutics is teaming with researchers from three Canadian universities to determine if RDT’s QuickStrip product is a more effective way to distribute cannabinoids than other oral methods.

The NFL is funding the research.

“This study has the potential to change not only the lives of current and former NFL players, but also the lives of anyone who may suffer from a concussion,” says Dr. Patrick Neary, exercise physiologist and professor in the Faculty of Kinesiology and Health Studies at the University of Regina, in a news release.

RDT’s QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, RDT says in the release.

Cannabinoids are the active ingredients in a cannabis plant “that are responsible for the way marijuana affects people,” according to the CNBS online cannabis journal.

THC and CBD are the best-known cannabinoids, but there are dozens of others “that are responsible for the way marijuana affects people—whether they’re enjoying it recreationally or using it to treat an illness,” the site says.